FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

782371005: Galcanezumab (substance)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 31-Jan 2019. Module: SNOMED CT core module

Descriptions:

Id Description Lang Type Status Case? Module
3753680011 Galcanezumab en Synonym Active Entire term case insensitive SNOMED CT core module
3753681010 Galcanezumab (substance) en Fully specified name Active Entire term case insensitive SNOMED CT core module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Galcanezumab Has disposition Calcitonin gene-related peptide receptor antagonist true Inferred relationship Existential restriction modifier
Galcanezumab Is a Monoclonal antibody true Inferred relationship Existential restriction modifier
Galcanezumab Is a Substance with calcitonin gene-related peptide receptor antagonist mechanism of action (substance) true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Galcanezumab Has active ingredient True Galcanezumab Inferred relationship Existential restriction modifier 1
Product containing galcanezumab (medicinal product) Has active ingredient True Galcanezumab Inferred relationship Existential restriction modifier 1
Product containing galcanezumab in parenteral dose form (medicinal product form) Has active ingredient True Galcanezumab Inferred relationship Existential restriction modifier 1
Product containing only galcanezumab in parenteral dose form (medicinal product form) Has active ingredient True Galcanezumab Inferred relationship Existential restriction modifier 1
Product containing precisely galcanezumab 120 milligram/1 milliliter conventional release solution for injection (clinical drug) Has precise active ingredient True Galcanezumab Inferred relationship Existential restriction modifier 1
Product containing precisely galcanezumab 120 milligram/1 milliliter conventional release solution for injection (clinical drug) Has basis of strength substance True Galcanezumab Inferred relationship Existential restriction modifier 1
Emgality 120mg/1ml solution for injection pre-filled pens (Eli Lilly and Company Ltd) 1 pre-filled disposable injection Has specific active ingredient True Galcanezumab Inferred relationship Existential restriction modifier
Emgality 120mg/1ml solution for injection pre-filled pens (Eli Lilly and Company Ltd) Has specific active ingredient True Galcanezumab Inferred relationship Existential restriction modifier
Galcanezumab 120mg/1ml solution for injection pre-filled disposable devices Has specific active ingredient True Galcanezumab Inferred relationship Existential restriction modifier
Galcanezumab 120mg/1ml solution for injection pre-filled disposable devices 1 pre-filled disposable injection Has specific active ingredient True Galcanezumab Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start